Peptide Research Glossary

A chemical modification where an acetyl group (CH₃CO−) is added to a molecule. In peptides, N-terminal acetylation protects the peptide from degradation by aminopeptidases, improving stability and half-life. Many research peptides are supplied in acetylated form.

A chemical modification at the C-terminus of a peptide where the carboxylic acid (−COOH) is replaced by an amide group (−CONH₂). C-terminal amidation increases peptide stability by protecting against carboxypeptidases and can also affect receptor binding affinity.

The fundamental building blocks of peptides and proteins. There are 20 standard amino acids, each with a unique side chain (R group). Amino acids are joined by peptide bonds formed between the carboxyl group of one amino acid and the amino group of the next, releasing water in the process.

A compound with structural similarity to a naturally occurring peptide, designed to mimic, enhance, or block its biological activity. Research analogues often have modifications to improve stability, potency, selectivity, or half-life compared to the endogenous parent peptide. Example: Semaglutide is an analogue of GLP-1.

Sterile water containing 0.9% benzyl alcohol as a preservative. The benzyl alcohol prevents microbial growth, making bacteriostatic water the preferred diluent for reconstituting peptides intended for multi-draw (repeated use) vials in research applications. Not for single-use applications where plain sterile saline is acceptable.

The fraction of a compound that reaches systemic circulation in active form relative to the administered dose. Subcutaneous (SubQ) bioavailability for most peptides is 70–90%. Oral bioavailability is typically very low (< 1–5%) due to proteolytic degradation in the GI tract, which is why most peptides require parenteral administration in research contexts.

The strength with which a peptide (ligand) binds to its receptor. Typically expressed as the dissociation constant (Kd) or inhibitory concentration (IC₅₀). Higher binding affinity (lower Kd value) means the peptide binds more tightly. Binding affinity is distinct from efficacy — a compound can have high affinity but low intrinsic activity (partial agonism).

An official document issued by an independent testing laboratory confirming the identity, purity, and quality of a compound. A standard peptide CoA includes the compound name, lot number, testing date, HPLC purity percentage, mass spectrometry identity confirmation, and the accredited lab name. CoAs should be requested for every peptide compound used in research.

Chemical Abstracts Service Registry Number. A unique numerical identifier assigned to every chemical substance in the CAS registry. Useful for confirming compound identity across suppliers and literature. Example: BPC-157 CAS Number is 137525-51-0.

The end of a peptide chain that terminates with a free carboxyl group (−COOH) unless modified (e.g., amidated). By convention, peptide sequences are written left to right from N-terminus to C-terminus. Many structural and stability modifications target the C-terminus.

The unit of molecular mass used for peptides and proteins. One dalton equals one-twelfth the mass of a carbon-12 atom (approximately 1.66 × 10⁻²⁷ kg). Small peptides (2–10 amino acids) typically have molecular weights of 200–1,200 Da. Larger peptides like GLP-1 analogues can exceed 4,000 Da. Also expressed as kDa (kilodalton, 1000 Da).

A covalent bond formed between the sulfur atoms of two cysteine residues. Disulfide bonds contribute to the three-dimensional structure and stability of many peptides and proteins. Disruption of disulfide bonds (by reducing agents like DTT or β-mercaptoethanol) can unfold the peptide and abolish activity.

Effective Concentration 50. The concentration of a compound required to produce 50% of the maximum possible biological effect in a given assay. A lower EC₅₀ indicates higher potency. Used alongside Emax (maximum effect) to characterize dose-response relationships.

Lipopolysaccharide (LPS) molecules derived from the outer membrane of gram-negative bacteria. Endotoxins are pyrogens — they cause immune activation and inflammatory responses even in trace amounts. Endotoxin contamination in research peptides can confound cell culture and in vivo study results. Tested by the LAL (Limulus Amebocyte Lysate) assay; expressed in EU/mg.

A mass spectrometry technique that ionizes compounds for analysis by spraying a liquid solution through a charged needle, producing multiply-charged ions. ESI-MS is widely used for confirming peptide molecular weight and identity. It generates multiple charge states of the same molecule, allowing accurate mass calculation even for larger peptides.

A shorter peptide derived from a larger protein or peptide sequence. Research fragments are often designed to preserve the active region (pharmacophore) of a parent compound while improving stability, selectivity, or ease of synthesis. Example: BPC-157 is a 15-amino acid fragment of the gastric juice protein body protection compound.

A peptide in which the C-terminus is left as a free carboxylic acid (−COOH) rather than being amidated. This is the most common form of synthetic peptides unless the product listing specifies "amide." Some peptides have different activity profiles depending on whether they are in free acid or amide form.

An incretin hormone produced in the intestinal L-cells in response to nutrient ingestion. GLP-1 stimulates glucose-dependent insulin secretion, inhibits glucagon release, slows gastric emptying, and suppresses appetite via central mechanisms. It is rapidly degraded by DPP-4 enzyme. GLP-1 receptor agonists (semaglutide, liraglutide) are stabilized analogues with extended half-lives.

A hypothalamic peptide that stimulates growth hormone (GH) synthesis and secretion from the pituitary gland. GHRH acts on the growth hormone-releasing hormone receptor (GHRHR) on pituitary somatotrophs. CJC-1295 (modified GRF 1-29) is a research analogue with extended half-life. Distinct from ghrelin-mimetic GHRPs, which act via a different receptor.

A class of synthetic peptides that stimulate GH release by acting on the ghrelin receptor (GHSR-1a). GHRPs work synergistically with GHRH analogues. Common GHRPs used in research include GHRP-2, GHRP-6, Hexarelin, and Ipamorelin. They differ in GH release potency, selectivity (cortisol/prolactin co-secretion), and appetite stimulation.

The time required for the concentration of a compound in a biological system to reduce to half its initial value. Relevant measures include plasma half-life (circulation) and biological half-life (activity duration). Most unmodified endogenous peptides have very short half-lives (minutes). Research peptides are often modified to extend half-life — fatty acid conjugation (semaglutide) or albumin binding (CJC-1295 DAC).

An analytical technique that separates, identifies, and quantifies components in a mixture by passing it under high pressure through a column packed with stationary phase material. For peptide purity analysis, reverse-phase HPLC (C18 column, UV detection at 220 nm) is the gold standard. Results are expressed as % peak area of the main compound relative to total chromatogram area.

Properties describing how a molecule interacts with water. Hydrophilic (water-loving) peptides are polar and dissolve readily in aqueous solutions. Hydrophobic (water-fearing) peptides prefer nonpolar environments and may require organic co-solvents (DMSO, acetonitrile) or acidic water for reconstitution. A peptide's hydrophobicity affects its solubility, cell membrane permeability, and receptor binding.

Inhibitory Concentration 50. The concentration of a compound required to inhibit a specific biological process (enzyme activity, receptor binding, cell proliferation) by 50%. A lower IC₅₀ indicates higher potency in inhibition assays. Distinct from EC₅₀, which applies to activation/stimulation assays.

A 70-amino acid peptide hormone structurally similar to insulin, primarily produced in the liver in response to GH stimulation. IGF-1 mediates many anabolic effects of GH. Research variants include IGF-1 LR3 (a 13-amino acid N-terminal extension plus Arg3 substitution that reduces binding protein affinity and extends half-life) and Des(1-3)IGF-1 (truncated N-terminal form).

Latin for "in glass" — refers to experiments conducted outside of a living organism, typically in cell cultures, test tubes, or other controlled laboratory environments. In vitro studies are a standard first step in peptide research but have limitations in predicting in vivo behavior due to differences in metabolism, distribution, and systemic interactions.

Latin for "within the living" — refers to experiments conducted in whole living organisms (animal models). In vivo studies provide more physiologically relevant data than in vitro models but require proper ethical approval and regulatory compliance. All research compounds sold by Trusted Peptides are for legitimate in vitro and preclinical in vivo research only.

A measure of binding affinity between a ligand and its receptor. Lower Kd values indicate tighter, higher-affinity binding. The Kd represents the concentration of ligand at which 50% of receptor binding sites are occupied at equilibrium. Typically expressed in nanomolar (nM) or picomolar (pM) for high-affinity peptide-receptor interactions.

A preservation process that removes water from a compound by first freezing it, then reducing pressure and gently heating to cause the ice to sublimate (convert directly from solid to vapor without passing through liquid state). Lyophilized peptides are more stable at room temperature and have longer shelf lives than solutions. Most research peptides are supplied lyophilized.

The physical form of a peptide that has been preserved via lyophilization. Typically appears as a white to off-white powder or cake inside a sealed amber glass vial. Lyophilized peptides must be reconstituted (dissolved) in an appropriate solvent before use. Storage at −20°C is recommended for maximum shelf life (typically 24+ months when kept dry and sealed).

A mass spectrometry technique that embeds the sample in a matrix compound, fires a laser to ionize the sample, and measures the time ions take to reach the detector. MALDI-TOF provides accurate molecular mass measurement for peptides and is commonly used for identity confirmation in quality control. It is particularly useful for larger peptides (> 3,000 Da).

The specific biochemical interaction through which a compound produces its biological effect. For peptides, MOA typically refers to receptor binding and the downstream signaling cascade that results. Understanding the MOA helps predict both desired effects and potential off-target interactions in research applications.

The chemical notation showing the exact number of each type of atom in a molecule. For peptides, the molecular formula describes the complete elemental composition. Example: BPC-157 has the molecular formula C₆₂H₉₈N₁₆O₂₂.

The sum of the atomic masses of all atoms in a molecule, expressed in Daltons (Da) or g/mol. Molecular weight is a key identifier for peptide characterization and is confirmed by mass spectrometry in quality control. It determines appropriate analytical methods and influences dosing calculations in research (e.g., converting mcg to nanomoles).

The end of a peptide chain that begins with a free amino group (−NH₂). By convention, peptide sequences are written left to right starting from the N-terminus. N-terminal acetylation is a common modification to improve stability. The N-terminus is important for many peptide-receptor interactions.

Biological effects produced by a compound acting on receptors or pathways other than its primary target. All research compounds have some degree of off-target activity, which must be characterized in research contexts. Understanding off-target effects is important for interpreting experimental results correctly.

A short chain of amino acids joined by peptide bonds (amide bonds between the carboxyl and amino groups of adjacent amino acids). By convention, peptides contain fewer than ~50 amino acids; larger chains are called polypeptides or proteins. Research peptides are synthetic versions of endogenous signaling molecules, designed to investigate specific receptor pathways.

The covalent bond formed between the α-carboxyl group of one amino acid and the α-amino group of the next, with loss of a water molecule (condensation reaction). Peptide bonds create the backbone of all peptide and protein structures. They are hydrolyzed (broken) by proteases (peptidases) — a key factor in the short biological half-life of most unmodified peptides.

The study of how a compound moves through a biological system — Absorption, Distribution, Metabolism, and Excretion (ADME). Key PK parameters for research peptides include: bioavailability (how much reaches circulation), Tmax (time to peak concentration), Cmax (peak concentration), and half-life. Understanding PK is essential for designing dosing protocols in animal studies.

The percentage of a sample that consists of the target compound, as measured by analytical techniques such as HPLC. Purity is expressed as "% by HPLC" or "% main peak area." Higher purity means fewer impurities, degradation products, and truncated sequences. Our minimum purity standard is ≥98% for all peptide compounds.

A compound that binds to a receptor and activates it, producing a biological response. Full agonists produce the maximum possible effect; partial agonists produce a sub-maximal effect even at saturating concentrations. Research peptides are typically agonists designed to mimic or enhance the effects of an endogenous ligand.

A compound that binds to a receptor but does not activate it, blocking the receptor from being activated by its endogenous ligand. Antagonists are used in research to study receptor function by blocking specific pathways. Some research peptides are designed as competitive antagonists.

The process of dissolving a lyophilized (freeze-dried) peptide powder into a liquid solvent to prepare it for use in research. Common reconstitution solvents include bacteriostatic water, sterile saline, and sterile water. Some peptides require acidified water (0.1% acetic acid) or DMSO. Always follow the specific reconstitution instructions for each compound; adding solvent down the vial wall and gently swirling (not vortexing) is standard practice.

The degree to which a compound preferentially binds to or affects one receptor or pathway over others. High selectivity means the compound acts primarily on its intended target with minimal off-target activity. Ipamorelin, for example, is noted for high selectivity for the GH axis with minimal effects on cortisol or prolactin compared to other GHRPs.

The order of amino acids in a peptide chain, written from N-terminus to C-terminus using one-letter or three-letter amino acid codes. Sequence determines a peptide's structure and function. Even a single amino acid substitution can dramatically alter activity, stability, or selectivity.

The standard method for synthesizing peptides in research and commercial production. Amino acids are added sequentially to a growing chain anchored to a solid resin support. Fmoc-SPPS is the most common approach for research peptides. After synthesis, the peptide is cleaved from the resin and purified, typically by preparative HPLC.

Referring to the layer of tissue beneath the skin (hypodermis). SubQ injection is a common administration route for peptides in research because it avoids first-pass hepatic metabolism, provides good bioavailability (70–90% for most peptides), and allows relatively slow, controlled absorption. SubQ peptide research typically uses small-gauge needles (27–31G) and rotating injection sites.

Time to Maximum Concentration. The time after administration at which a compound reaches its peak plasma concentration. SubQ-administered peptides typically reach Tmax in 30–90 minutes. Cmax and Tmax together describe the absorption phase of a compound's pharmacokinetic profile.

An incomplete version of a peptide that arises from incomplete synthesis (missed coupling reaction) or degradation. Truncated sequences are a common impurity in peptide synthesis and can reduce apparent purity as measured by HPLC. Mass spectrometry can identify truncated sequences that co-elute with the main compound on HPLC, which is why both techniques are used together in rigorous QC.

Highly purified water meeting United States Pharmacopeia (USP) standards for sterility and pyrogen content. Used as a solvent and diluent in pharmaceutical and research applications. WFI is sterile, endotoxin-tested, and free of organic impurities. It differs from bacteriostatic water in that it contains no preservative.

A small sealed glass container used to store lyophilized research compounds. Amber glass protects light-sensitive compounds from UV-induced degradation. Research peptide vials are typically sealed under nitrogen with a rubber stopper (septum) and aluminum crimp cap, allowing needle access while maintaining sterility. Store away from light and at −20°C when not in use.